Article
αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Neuropharmacology - 1 Dec 2017
Zhangsun Dongting, Zhu Xiaopeng, Kaas Quentin, Wu Yong, Craik David J, McIntosh J Michael, Luo Sulan
Abstract excerpt
Nicotinic acetylcholine receptor (nAChR) subtypes exhibit distinct neuropharmacological properties that are involved in a range of neuropathological conditions, including pain, addiction, epilepsy, autism, schizophrenia, Tourette's syndrome, Alzheimer's and Parkinson's diseases, as well as many types of cancer. The α9α10 nAChR is a potential target in chronic pain, wound healing, the pathophysiology of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
